All Stories

  1. The inflammatory endotype in osteoarthritis: Reflections from the 2024 OARSI clinical trials symposium (CTS) with a special emphasis on feasibility for clinical development
  2. Comment on “Surgical restabilization reduces the progression of post-traumatic osteoarthritis initiated by ACL rupture in mice” by Lin et al. (2024), and recommendations for non-invasive knee joint injury models
  3. Multifaceted imaging strategies for clinical trials of knee osteoarthritis—a tightly interlinked value and precision chain
  4. Advances in Extracellular Matrix-Associated Diagnostics and Therapeutics
  5. Comment on “Effectiveness and safety of intra-articular interventions for knee and hip osteoarthritis based on large randomized trials: A systematic review and network meta-analysis (Pereira et al., 2025)”
  6. TissueGene-C induces anti-inflammatory activity and M2 macrophage polarization via activation of prostaglandin E2 signaling
  7. Development of a Microphysiological Cartilage‐on‐Chip Platform for Dynamic Biomechanical Stimulation of Three‐Dimensional Encapsulated Chondrocytes in Agarose Hydrogels
  8. Obesity-induced fibrosis in osteoarthritis: Pathogenesis, consequences and novel therapeutic opportunities
  9. Correction: Giunta et al. Ameliorative Effects of PACAP against Cartilage Degeneration. Morphological, Immunohistochemical and Biochemical Evidence from in Vivo and in Vitro Models of Rat Osteoarthritis. Int. J. Mol. Sci. 2015, 16, 5922–5944
  10. Targeting the TRPV1 pain pathway in osteoarthritis of the knee
  11. Do we understand sex-related differences governing dimorphic disease mechanisms in preclinical animal models of osteoarthritis?
  12. The interplay between inflammatory mediators and mechanotransduction is mediated by ion channels in articular chondrocytes: Functional consequences in osteoarthritis
  13. Visual narratives in medicine – Bridging the gap in graphic medicine with an illustrated narrative of osteoarthritis
  14. Clinical phenotypes, molecular endotypes and theratypes in OA therapeutic development
  15. Age and anatomical region‐related differences in vascularization of the porcine meniscus using microcomputed tomography imaging
  16. Ion Channels As Emerging Metabolic Regulators and Therapeutic Targets in Osteoarthritis: Nav1.7 As a Recent Exemplar
  17. Evidence-Based Opinions from Multidisciplinary Experts on Use of Naturopathic Herbal Remedies in Pain Management
  18. The interplay between dysregulated metabolites and signaling pathway alterations involved in osteoarthritis: a systematic review
  19. The Potential Role of Ionic Liquid as a Multifunctional Dental Biomaterial
  20. Age and anatomical region related differences in vascularization of the porcine meniscus using micro-computed tomography imaging
  21. Hepatic encephalopathy complications are diminished by piracetam via the interaction between mitochondrial function, oxidative stress, inflammatory response, and locomotor activity
  22. The Potential Role of Probiotics in the Management of Osteoarthritis Pain: Current Status and Future Prospects
  23. Evaluation of Cartilage Integrity following Administration of Oral and Intraarticular Nifedipine in a Murine Model of Osteoarthritis
  24. Low‐dose ketamine improves animals' locomotor activity and decreases brain oxidative stress and inflammation in ammonia‐induced neurotoxicity
  25. Ion channels involved in inflammation and pain in osteoarthritis and related musculoskeletal disorders
  26. Biomarkers for osteoarthritis: Current status and future prospects
  27. The Effect of CaV1.2 Inhibitor Nifedipine on Chondrogenic Differentiation of Human Bone Marrow or Menstrual Blood-Derived Mesenchymal Stem Cells and Chondrocytes
  28. “Self-Healing”: A Novel and Integrated Multimodal Concept for the Management of Musculoskeletal Pain
  29. Osteoarthritis
  30. Intra-Articular Injection of Platelet-Rich Plasma Is More Effective than Hyaluronic Acid or Steroid Injection in the Treatment of Mild to Moderate Knee Osteoarthritis: A Prospective, Randomized, Triple-Parallel Clinical Trial
  31. Osteoarthritis endotype discovery via clustering of biochemical marker data
  32. Minimally Invasive Cell-Based Therapy for Symptomatic Bone Marrow Lesions of the Knee: A Prospective Clinical Study at 1 Year
  33. Predicting osteoarthritis onset and progression with 3D texture analysis of cartilage MRI DESS: 6‐Year data from osteoarthritis initiative
  34. Magneto-Immunoassay for the Detection and Quantification of Human Growth Hormone
  35. Exploring the translational potential of clusterin as a biomarker of early osteoarthritis
  36. Therapeutic Perspectives for the Clinical Application of Umbilical Cord Hematopoietic and Mesenchymal Stem Cells: Overcoming Complications Arising After Allogeneic Hematopoietic Stem Cell Transplantation
  37. A new immunometabolic perspective of intervertebral disc degeneration
  38. A White Paper on Collagen Hydrolyzates and Ultrahydrolyzates: Potential Supplements to Support Joint Health in Osteoarthritis?
  39. Cardiovascular Drugs and Osteoarthritis: Effects of Targeting Ion Channels
  40. Early-stage symptomatic osteoarthritis of the knee — time for action
  41. Molecular-Morphological Relationships of the Scaffold Protein FKBP51 and Inflammatory Processes in Knee Osteoarthritis
  42. Exogenous stromal cell-derived factor-1 (SDF-1) suppresses the NLRP3 inflammasome and inhibits pyroptosis in synoviocytes from osteoarthritic joints via activation of the AMPK signaling pathway
  43. A Prospective Study Comparing Leukocyte-Poor Platelet-Rich Plasma Combined with Hyaluronic Acid and Autologous Microfragmented Adipose Tissue in Patients with Early Knee Osteoarthritis
  44. The Effect of Platelet-Rich Plasma on the Intra-Articular Microenvironment in Knee Osteoarthritis
  45. Drug‐induced organ injury in coronavirus disease 2019 pharmacotherapy: Mechanisms and challenges in differential diagnosis and potential protective strategies
  46. Monomeric C reactive protein (mCRP) regulates inflammatory responses in human and mouse chondrocytes
  47. Exogenous Stromal Cell-Derived Factor-1 (SDF-1) Suppresses the NLRP3 Inflammasome and Inhibits Pyroptosis in Synoviocytes from Osteoarthritic Joints via Activation of the AMPK Signaling Pathway
  48. Podcasting: An innovative tool for enhanced osteoarthritis education and research dissemination
  49. The role of metabolism in chondrocyte dysfunction and the progression of osteoarthritis
  50. An Update on the Role of Leptin in the Immuno-Metabolism of Cartilage
  51. Targeting mitochondrial dysfunction with small molecules in intervertebral disc aging and degeneration
  52. Reevolution of Tissue Regeneration: From Recent Advances in Adipose Stem Cells to Novel Therapeutic Approaches
  53. Neuroscience and Neuroimmunology Solutions for Osteoarthritis Pain: Biological Drugs, Growth Factors, Peptides and Monoclonal Antibodies Targeting Peripheral Nerves
  54. The future of deep phenotyping in osteoarthritis: how can high throughput omics technologies advance our understanding of the cellular and molecular taxonomy of the disease?
  55. Elephants, Mobility and Captivity: What Can These Mighty and Majestic Animals Teach Us About Joint Health and Osteoarthritis?
  56. Neuroscience and Neuroimmunology Solutions for Osteoarthritis Pain: Biological Drugs, Growth Factors, Peptides and Monoclonal Antibodies Targeting Peripheral Nerves
  57. Prospective study comparing leukocyte-poor platelet rich plasma combined with hyaluronic acid and autologous microfragmented adipose tissue in patients with early knee osteoarthritis.
  58. Biosensors for the Multiplex Detection of Inflammatory Disease Biomarkers
  59. Elephants, Mobility and Captivity: What Can These Mighty and Majestic Animals Teach Us About Joint Health and Osteoarthritis?
  60. Multiplexed Nanobiosensors: Current Trends in Early Diagnostics
  61. Characterization of Individuals with Osteoarthritis in the United States and Their Use of Prescription and Over-the-Counter Supplements
  62. Non-surgical management of knee osteoarthritis: comparison of ESCEO and OARSI 2019 guidelines
  63. Over-Production of Therapeutic Growth Factors for Articular Cartilage Regeneration by Protein Production Platforms and Protein Packaging Cell Lines
  64. Physiological Effects of the Electrogenic Current Generated by the Na /K Pump in Mammalian Articular Chondrocytes
  65. Clusterin secretion is attenuated by the proinflammatory cytokines interleukin‐1β and tumor necrosis factor‐α in models of cartilage degradation
  66. Over-production of Therapeutic Growth Factors for Articular Cartilage Regeneration by Protein Production Platforms and Protein Packaging Cell Lines
  67. COVID-19, osteoarthritis and women's health
  68. Alterations in the chondrocyte surfaceome in response to pro-inflammatory cytokines
  69. Combining segmental bulk- and single-cell RNA-sequencing to define the chondrocyte gene expression signature in the murine knee joint
  70. Multi-classifier prediction of knee osteoarthritis progression from incomplete imbalanced longitudinal data
  71. Clusterin secretion is attenuated by pro-inflammatory cytokines in culture models of cartilage degradation
  72. Nanotechnological Strategies for Osteoarthritis Diagnosis, Monitoring, Clinical Management, and Regenerative Medicine: Recent Advances and Future Opportunities
  73. Pro-inflammatory Cytokines Drive Deregulation of Potassium Channel Expression in Primary Synovial Fibroblasts
  74. A consensus-based framework for conducting and reporting osteoarthritis phenotype research
  75. Vertically aligned carbon nanotube micropillars induce unidirectional chondrocyte orientation
  76. Biomarkers of fitness and welfare in dairy cattle: healthy productivity
  77. Cell and Gene Therapy for Spine Regeneration
  78. Recent advances in understanding the phenotypes of osteoarthritis
  79. Biomarkers of fitness and welfare in dairy animals: healthy living
  80. The Antihypertensive Drug Nifedipine Modulates the Metabolism of Chondrocytes and Human Bone Marrow-Derived Mesenchymal Stem Cells
  81. Alterations in the chondrocyte surfaceome in response to pro-inflammatory cytokines
  82. Over-Production of Therapeutic Growth Factors for Cartilage Regeneration by Protein Production Platforms and Protein Packaging Cell Lines: A Narrative Review of the Current State-of-the-Art
  83. Coll2-1 and Coll2-1NO2 as exemplars of collagen extracellular matrix turnover - biomarkers to assist the treatment of osteoarthritis?
  84. Tofacitinib and TPCA-1 exert chondroprotective effects on extracellular matrix turnover in bovine articular cartilage ex vivo
  85. Osteoarthritis (OA): A Modern Disease of the Anthropocene Era
  86. The Role of Advanced MRI in the Development of Treat-to-Target Therapeutic Strategies, Patient Stratification and Phenotyping in Rheumatoid Arthritis
  87. The Antihypertensive Drug Nifedipine Modulates the Metabolism of Chondrocytes and Human Bone Marrow-Derived Mesenchymal Stem Cells
  88. Molecular phenotyping of the surfaceome of migratory chondroprogenitors and mesenchymal stem cells using biotinylation, glycocapture and quantitative LC-MS/MS proteomic analysis
  89. Establishing outcome measures in early knee osteoarthritis
  90. Molecular phenotyping of the surfaceome of migratory chondroprogenitors and mesenchymal stem cells using biotinylation, glycocapture and quantitative LC-MS/MS proteomic analysis
  91. Strategies for optimising musculoskeletal health in the 21st century
  92. Natural Molecules for Healthy Lifestyles: Oleocanthal from Extra Virgin Olive Oil
  93. Adipokines: Linking metabolic syndrome, the immune system, and arthritic diseases
  94. Osteoarthritis phenotypes and novel therapeutic targets
  95. Le « channelome » du chondrocyte. Revue narrative
  96. Uptake of the OMERACT-OARSI Hip and Knee Osteoarthritis Core Outcome Set: Review of Randomized Controlled Trials from 1997 to 2017
  97. IQGAP1, AmotL2, and FKBP51 Scaffoldins in the Glioblastoma Microenvironment
  98. Comment on: Efficacy of Curcumin and Boswellia for knee osteoarthritis: Systematic review and meta-analysis
  99. The OMERACT-OARSI Core Domain Set for Measurement in Clinical Trials of Hip and/or Knee Osteoarthritis
  100. A correlation between intestinal microbiota dysbiosis and osteoarthritis
  101. A systematic review of osteoarthritis prevention and management with dietary phytochemicals from foods
  102. Homeobox Genes and Homeodomain Proteins: New Insights into Cardiac Development, Degeneration and Regeneration
  103. Molecular taxonomy of osteoarthritis for patient stratification, disease management and drug development
  104. The chondrocyte channelome: A narrative review
  105. The Potential of Menstrual Blood-Derived Mesenchymal Stem Cells for Cartilage Repair and Regeneration: Novel Aspects
  106. A Novel High Sensitivity Type II Collagen Blood-Based Biomarker, PRO-C2, for Assessment of Cartilage Formation
  107. The Role of Physical Stimuli on Calcium Channels in Chondrogenic Differentiation of Mesenchymal Stem Cells
  108. Natural Products for Promoting Joint Health and Managing Osteoarthritis
  109. Aggrecanase degradation of type III collagen is associated with clinical knee pain
  110. What is the evidence for a role for diet and nutrition in osteoarthritis?
  111. Adipokines and inflammation: is it a question of weight?
  112. Which supplements can I recommend to my osteoarthritis patients?
  113. A Comprehensive Review of Stem Cells for Cartilage Regeneration in Osteoarthritis
  114. Bioengineered Scaffolds for Stem Cell Applications in Tissue Engineering and Regenerative Medicine
  115. Biomaterials for Regenerative Medicine: Historical Perspectives and Current Trends
  116. Development and use of biochemical markers in osteoarthritis
  117. Extracellular genomic biomarkers of osteoarthritis
  118. Gestation changes sodium pump isoform expression, leading to changes in ouabain sensitivity, contractility, and intracellular calcium in rat uterus
  119. The Na, K-ATPase β-Subunit Isoforms Expression in Glioblastoma Multiforme: Moonlighting Roles
  120. Aging and osteoarthritis: Central role of the extracellular matrix
  121. Biochemical marker discovery, testing and evaluation for facilitating OA drug discovery and development
  122. Progranulin as a biomarker and potential therapeutic agent
  123. Soluble biochemical markers of osteoarthritis: Are we close to using them in clinical practice?
  124. Engineered cartilage regeneration from adipose tissue derived-mesenchymal stem cells: A morphomolecular study on osteoblast, chondrocyte and apoptosis evaluation
  125. Alterations in IQGAP1 expression and localization in colorectal carcinoma and liver metastases following oxaliplatin-based chemotherapy
  126. Commitment of Scaffold Proteins in the Onco-Biology of Human Colorectal Cancer and Liver Metastases after Oxaliplatin-Based Chemotherapy
  127. LEF1-mediated MMP13 gene expression is repressed by SIRT1 in human chondrocytes
  128. The role of metabolism in the pathogenesis of osteoarthritis
  129. The minor collagens in articular cartilage
  130. Chondrocyte secretome: a source of novel insights and exploratory biomarkers of osteoarthritis
  131. Osteoarthritis Year in Review 2016: biomarkers (biochemical markers)
  132. IQGAP1 in Podosomes/Invadosomes Is Involved in the Progression of Glioblastoma Multiforme Depending on the Tumor Status
  133. IQGAP1 in Podosomes/Invadosomes Is Involved in the Progression of Glioblastoma Multiforme Depending on the Tumor Status
  134. IQGAP1 in Podosome /Invadosome is Involved in the Progression of Glioblastoma Multiforme Depending on the Tumor Status
  135. The Potency of Induced Pluripotent Stem Cells in Cartilage Regeneration and Osteoarthritis Treatment
  136. Adipose, Bone Marrow and Synovial Joint-Derived Mesenchymal Stem Cells for Cartilage Repair
  137. An update on the pathophysiology of osteoarthritis
  138. IQGAP1 in Podosome /Invadosome is Involved in the Progression of Glioblastoma Multiforme Depending on the Tumor Status
  139. Age-Related Alterations in Signaling Pathways in Articular Chondrocytes: Implications for the Pathogenesis and Progression of Osteoarthritis - A Mini-Review
  140. Applying Proteomics to Study Crosstalk at the Cartilage-Subchondral Bone Interface in Osteoarthritis: Current Status and Future Directions
  141. In vitro models of cancer stem cells and clinical applications
  142. Reply to “Comment on: Inflammatory mediators in osteoarthritis: A critical review of the state-of-the art, prospects, and future challenges”
  143. The Role of Sirtuins in Cartilage Homeostasis and Osteoarthritis
  144. Altered joint tribology in osteoarthritis: Reduced lubricin synthesis due to the inflammatory process. New horizons for therapeutic approaches
  145. Osteoarthritis biomarkers derived from cartilage extracellular matrix: Current status and future perspectives
  146. Pelleted Bone Marrow Derived Mesenchymal Stem Cells Are Better Protected from the Deleterious Effects of Arthroscopic Heat Shock
  147. The Need for Predictive, Prognostic, Objective and Complementary Blood-Based Biomarkers in Osteoarthritis (OA)
  148. Immune Modulation of Inammation in Neurodegenerative Diseases: Alzheimer’s Disease and Amyotrophic Lateral Sclerosis
  149. Mesenchymal stem cells: Identification, phenotypic characterization, biological properties and potential for regenerative medicine through biomaterial micro-engineering of their niche
  150. Inflammatory mediators in osteoarthritis: A critical review of the state-of-the-art, current prospects, and future challenges
  151. Mesenchymal stem cells in regenerative medicine: Focus on articular cartilage and intervertebral disc regeneration
  152. Faculty of 1000 evaluation for Aging Promotes SIRT3-dependent Cartilage SOD2 Acetylation and Osteoarthritis.
  153. Faculty of 1000 evaluation for Elucidating the Molecular Composition of Cartilage by Proteomics.
  154. Atenolol Reduces Leishmania major-Induced Hyperalgesia and TNF-α Without Affecting IL-1β or Keratinocyte Derived Chemokines (KC)
  155. Na,K-ATPase Isozymes in Colorectal Cancer and Liver Metastases
  156. Post-operative rehabilitation and nutrition in osteoarthritis
  157. Osteoarthritis year in review 2015: soluble biomarkers and the BIPED criteria
  158. Effect of Prenatal and Neonatal Anti-Androgen Flutamide Treatment on Aquaporin 5 Expression in the Adult Porcine Ovary
  159. Biomarkers of (osteo)arthritis
  160. Label-free proteomic analysis of the hydrophobic membrane protein complement in articular chondrocytes: a technique for identification of membrane biomarkers
  161. The potential of lipocalin-2/NGAL as biomarker for inflammatory and metabolic diseases
  162. Leptin in osteoarthritis: Focus on articular cartilage and chondrocytes
  163. Mesenchymal Stem Cells and their Potential for Microengineering the Chondrocyte Niche
  164. Cobalt chloride doping in racehorses: Concerns over a potentially lethal practice
  165. Biomarkers of Chondrocyte Apoptosis and Autophagy in Osteoarthritis
  166. Comparative Medicine in the Twenty-First Century: Where are We Now and Where Do We Go from Here?
  167. Voltage-Dependent Calcium Channels in Chondrocytes: Roles in Health and Disease
  168. Osteoarthritis in the XXIst Century: Risk Factors and Behaviours that Influence Disease Onset and Progression
  169. Ameliorative Effects of PACAP against Cartilage Degeneration. Morphological, Immunohistochemical and Biochemical Evidence from in Vivo and in Vitro Models of Rat Osteoarthritis
  170. Physicochemical and Biomechanical Stimuli in Cell-Based Articular Cartilage Repair
  171. Chondrosenescence: Definition, hallmarks and potential role in the pathogenesis of osteoarthritis
  172. The crossroads between cancer stem cells and aging
  173. A machine learning heuristic to identify biologically relevant and minimal biomarker panels from omics data
  174. Physiology and Pathophysiology of Musculoskeletal Aging
  175. Corrigendum to: What is the current status of chondroitin sulfate and glucosamine for the treatment of knee osteoarthritis? Maturitas 78 (2014) 184–187
  176. High hopes for cannabinoid agonists in the treatment of rheumatic diseases
  177. Ser/Thr-phosphoprotein phosphatases in chondrogenesis: neglected components of a two-player game
  178. Biosynthesis of collagen I, II, RUNX2 and lubricin at different time points of chondrogenic differentiation in a 3D in vitro model of human mesenchymal stem cells derived from adipose tissue
  179. Faculty Opinions recommendation of A biphasic multiscale study of the mechanical microenvironment of chondrocytes within articular cartilage under unconfined compression.
  180. Faculty Opinions recommendation of Inflammation induces irreversible biophysical changes in isolated nucleus pulposus cells.
  181. Faculty Opinions recommendation of The Kardashian index: a measure of discrepant social media profile for scientists.
  182. Faculty Opinions recommendation of Publication metrics and success on the academic job market.
  183. Peripheral Calcitonin Gene‐Related Peptide Receptor Activation and Mechanical Sensitization of the Joint in Rat Models of Osteoarthritis Pain
  184. Physical activity ameliorates cartilage degeneration in a rat model of aging: A study on lubricin expression
  185. Faculty Opinions recommendation of Role of dentin matrix protein 1 in cartilage redifferentiation and osteoarthritis.
  186. Faculty Opinions recommendation of The active form of MMP-3 is a marker of synovial inflammation and cartilage turnover in inflammatory joint diseases.
  187. Faculty Opinions recommendation of Targeting pro-inflammatory cytokines following joint injury: acute intra-articular inhibition of interleukin-1 following knee injury prevents post-traumatic arthritis.
  188. What is the current status of chondroitin sulfate and glucosamine for the treatment of knee osteoarthritis?
  189. Chondrocyte and mesenchymal stem cell-based therapies for cartilage repair in osteoarthritis and related orthopaedic conditions
  190. Faculty Opinions recommendation of Effect of physical therapy on pain and function in patients with hip osteoarthritis: a randomized clinical trial.
  191. Lubricin expression in human osteoarthritic knee meniscus and synovial fluid: A morphological, immunohistochemical and biochemical study
  192. Post-operative rehabilitation in osteoarthritis
  193. Post-operative rehabilitation in osteoarthritis 
  194. Faculty Opinions recommendation of A single blunt impact on cartilage promotes fibronectin fragmentation and upregulates cartilage degrading stromelysin-1/matrix metalloproteinase-3 in a bovine ex vivo model.
  195. Faculty Opinions recommendation of Effect of oral glucosamine on joint structure in individuals with chronic knee pain: a randomized, placebo-controlled clinical trial.
  196. Faculty Opinions recommendation of Cav3.2 T-type calcium channel is required for the NFAT-dependent Sox9 expression in tracheal cartilage.
  197. Regulation of chondrogenesis by protein kinase C: Emerging new roles in calcium signalling
  198. Faculty Opinions recommendation of FK506 protects against articular cartilage collagenous extra-cellular matrix degradation.
  199. Faculty Opinions recommendation of Articular cartilage chondrocytes express aromatase and use enzymes involved in estrogen metabolism.
  200. Faculty Opinions recommendation of Underlying molecular mechanisms of DIO2 susceptibility in symptomatic osteoarthritis.
  201. Immunolocalization of aquaporin 5 during rat ovarian follicle development and expansion of the preovulatory cumulus oophorus
  202. Biomarkers of osteoarthritis: translating information from in vitro culture systems to human patients
  203. Effect of osmotic stress on the expression of TRPV4 and BKCa channels and possible interaction with ERK1/2 and p38 in cultured equine chondrocytes
  204. Water intake, faecal output and intestinal motility in horses moved from pasture to a stabled management regime with controlled exercise
  205. Faculty Opinions recommendation of The CRAPome: a contaminant repository for affinity purification-mass spectrometry data.
  206. Faculty Opinions recommendation of Cleaning up the masses: exclusion lists to reduce contamination with HPLC-MS/MS.
  207. Faculty Opinions recommendation of Culture expansion in low-glucose conditions preserves chondrocyte differentiation and enhances their subsequent capacity to form cartilage tissue in three-dimensional culture.
  208. Faculty Opinions recommendation of Mesenchymal stem cells: immune evasive, not immune privileged.
  209. Faculty Opinions recommendation of Cell senescence abrogates the therapeutic potential of human mesenchymal stem cells in the lethal endotoxemia model.
  210. Faculty Opinions recommendation of Cobalt chloride induces neuronal differentiation of human mesenchymal stem cells through upregulation of microRNA-124a.
  211. Effects of cyclic equibiaxial mechanical stretch on α-BK and TRPV4 expression in equine chondrocytes
  212. Antioxidants and Osteoarthritis
  213. Carprofen inhibits the release of matrix metalloproteinases 1, 3, and 13 in the secretome of an explant model of articular cartilage stimulated with interleukin 1β
  214. Faculty Opinions recommendation of NFATc1 and NFATc2 repress spontaneous osteoarthritis.
  215. Faculty Opinions recommendation of Osteoarthritis as an inflammatory disease (osteoarthritis is not osteoarthrosis!).
  216. Faculty Opinions recommendation of Two non-coding RNAs, MicroRNA-101 and HOTTIP contribute cartilage integrity by epigenetic and homeotic regulation of integrin-α1.
  217. Faculty Opinions recommendation of Osteoarthritis year 2013 in review: biomarkers; reflecting before moving forward, one step at a time.
  218. Faculty Opinions recommendation of Differentiation of muscle, fat, cartilage, and bone from progenitor cells present in a bone-derived clonal cell population: effect of dexamethasone.
  219. Faculty Opinions recommendation of Flexural properties of native and tissue-engineered human septal cartilage.
  220. Faculty Opinions recommendation of Differentiation of adipose-derived stem cells into contractile smooth muscle cells induced by transforming growth factor-beta1 and bone morphogenetic protein-4.
  221. Faculty Opinions recommendation of Cytokine signaling-1 suppressor is inducible by IL-1beta and inhibits the catabolic effects of IL-1beta in chondrocytes: its implication in the paradoxical joint-protective role of IL-1beta.
  222. Aquaporin Water Channels in the Mammary Gland: From Physiology to Pathophysiology and Neoplasia
  223. Faculty Opinions recommendation of Detection of tumor necrosis factor alpha but not tumor necrosis factor beta in rheumatoid arthritis synovial fluid and serum.
  224. Faculty Opinions recommendation of Migratory chondrogenic progenitor cells from repair tissue during the later stages of human osteoarthritis.
  225. Faculty Opinions recommendation of iTRAQ-based proteomics reveals novel biomarkers of osteoarthritis.
  226. Faculty Opinions recommendation of In Vivo luminescent imaging of NF-κB activity and serum cytokine levels predict pain sensitivities in a rodent model of osteoarthritis.
  227. Faculty Opinions recommendation of Hypercholesterolemia boosts joint destruction in chronic arthritis. An experimental model aggravated by foam macrophage infiltration.
  228. Faculty Opinions recommendation of Interleukin-1 beta and tumor necrosis factor alpha inhibit migration activity of chondrogenic progenitor cells from non-fibrillated osteoarthritic cartilage.
  229. Faculty Opinions recommendation of An explorative study comparing levels of soluble mediators in control and osteoarthritic synovial fluid.
  230. Faculty Opinions recommendation of Hypoxia promotes redifferentiation and suppresses markers of hypertrophy and degeneration in both healthy and osteoarthritic chondrocytes.
  231. Faculty Opinions recommendation of Release of cartilage oligomeric matrix protein (COMP) into joint fluid after knee injury and in osteoarthritis.
  232. Faculty Opinions recommendation of IL-17 inhibits chondrogenic differentiation of human mesenchymal stem cells.
  233. Faculty Opinions recommendation of Evidence that TNF-β (lymphotoxin α) can activate the inflammatory environment in human chondrocytes.
  234. Faculty Opinions recommendation of Chondrogenesis of mesenchymal stem cells in an osteochondral environment is mediated by the subchondral bone.
  235. Faculty Opinions recommendation of Macrophage migration inhibitory factor regulates AKT signaling in hypoxic culture to modulate senescence of human mesenchymal stem cells.
  236. Application of Machine Learning to Proteomics Data: Classification and Biomarker Identification in Postgenomics Biology
  237. Analysis of mass spectrometry data from the secretome of an explant model of articular cartilage exposed to pro-inflammatory and anti-inflammatory stimuli using machine learning
  238. Chondrocyte channel transcriptomics
  239. The Future of Osteoarthritis Therapeutics: Emerging Biological Therapy
  240. The Future of Osteoarthritis Therapeutics: Targeted Pharmacological Therapy
  241. Bacterial lipopolysaccharides form procollagen-endotoxin complexes that trigger cartilage inflammation and degeneration: implications for the development of rheumatoid arthritis
  242. Curcumin reduces prostaglandin E2, matrix metalloproteinase-3 and proteoglycan release in the secretome of interleukin 1β-treated articular cartilage
  243. Curcumin reduces prostaglandin E2, matrix metalloproteinase-3 and proteoglycan release in the secretome of interleukin 1β-treated articular cartilage
  244. Aquaporin water channels in the canine gubernaculum testis
  245. Osteogenic effects of resveratrol in vitro: potential for the prevention and treatment of osteoporosis
  246. Expression and function of K(ATP) channels in normal and osteoarthritic human chondrocytes: Possible role in glucose sensing
  247. Faculty Opinions recommendation of The cell surface proteome of human mesenchymal stromal cells.
  248. Faculty Opinions recommendation of Proteome analysis during chondrocyte differentiation in a new chondrogenesis model using human umbilical cord stroma mesenchymal stem cells.
  249. Exploring the serum proteome in dogs: Setting the scene for the discovery of new biomarkers in canine lymphoma
  250. Tissue Engineered Animal Sparing Models for the Study of Joint and Muscle Diseases
  251. High-throughput proteomic analysis of the cartilage secretome for identification of inflammatory biomarkers
  252. Sample classification and identification of biomarkers in the cartilage secretome from mass spectrometry datasets using machine learning
  253. Physiological effects of oral glucosamine on joint health: current status and consensus on future research priorities
  254. Benzamil sensitive ion channels contribute to volume regulation in canine chondrocytes
  255. Nonpharmacological modalities, nutraceuticals and dietary supplements as therapies
  256. Curcumin Enhances the Effect of Chemotherapy against Colorectal Cancer Cells by Inhibition of NF-κB and Src Protein Kinase Signaling Pathways
  257. Curcumin: a new paradigm and therapeutic opportunity for the treatment of osteoarthritis: curcumin for osteoarthritis management
  258. Physiology and pathophysiology of musculoskeletal aging: current research trends and future priorities
  259. Soluble Proteomic Biomakers in the Management of Arthritis
  260. Antioxidants in the Treatment of Osteoarthritis and Bone Mineral Loss
  261. Osteoarthritis year 2012 in review: biomarkers
  262. Potassium channels in articular chondrocytes
  263. Intersection of Inflammation and Herbal Medicine in the Treatment of Osteoarthritis
  264. Resveratrol Modulates Interleukin-1 -induced Phosphatidylinositol 3-Kinase and Nuclear Factor  B Signaling Pathways in Human Tenocytes
  265. Editorial: [Hot Topic: Epigenetics in Arthritis]
  266. Sirt-1 Is Required for the Inhibition of Apoptosis and Inflammatory Responses in Human Tenocytes
  267. Identification and phenotypic characterisation of chondroprogenitor cells for the repair of equine articular cartilage
  268. Expression of aquaporin water channels in canine fetal adnexa in respect to the regulation of amniotic fluid production and absorption
  269. Resveratrol Mediated Modulation of Sirt-1/Runx2 Promotes Osteogenic Differentiation of Mesenchymal Stem Cells: Potential Role of Runx2 Deacetylation
  270. Nutraceuticals: From Research to Legal and Regulatory Affairs
  271. Na+, K+-ATPase Subunit Composition in a Human Chondrocyte Cell Line; Evidence for the Presence of α1, α3, β1, β2 and β3 Isoforms
  272. Expression of Transient Receptor Potential Vanilloid (TRPV) Channels in Different Passages of Articular Chondrocytes
  273. Year in review: biomarkers
  274. Proteomic and bioinformatic analysis of hydrophobic membrane protein extracts reveals the presence of several novel CD antigens, glucose transporters and voltage gated anion channels in articular chondrocytes
  275. Scientific Evidence and Rationale for the Development of Curcumin and Resveratrol as Nutraceutricals for Joint Health
  276. Three‐Dimensional, High‐Density and Tissue Engineered Culture Models of Articular Cartilage
  277. Proteomic Profiling and Its Applications to Muscle Aging and Sarcopenia
  278. Is there any scientific evidence for the use of glucosamine in the management of human osteoarthritis?
  279. Glucose: an energy currency and structural precursor in articular cartilage and bone with emerging roles as an extracellular signaling molecule and metabolic regulator
  280. Botanical Extracts from Rosehip (Rosa canina), Willow Bark (Salix alba), and Nettle Leaf (Urtica dioica) Suppress IL-1β-Induced NF-κB ...
  281. The biology of equine mesenchymal stem cells: phenotypic characterization, cell surface markers and multilineage differentiation
  282. IGF-1 and PDGF-bb Suppress IL-1β-Induced Cartilage Degradation through Down-Regulation of NF-κB Signaling: Involvement of Src/PI-3K/AKT Pathway
  283. Hypoxia and a hypoxia mimetic up-regulate matrix metalloproteinase 2 and 9 in equine laminar keratinocytes
  284. Identification and validation of early biomarkers of osteoarthritis in companion animals: Are we ready for the challenge?
  285. T105 ACUTE BLOCKADE OF CALCITONIN GENE-RELATED PEPTIDE RECEPTORS INHIBITS RESPONSES OF KNEE JOINT PRIMARY AFFERENTS IN THE MIA MODEL OF OSTEOARTHRITIS
  286. 453 NOVEL BIOINFORMATIC APPROACHES FOR IDENTIFYING PUTATIVE OA BIOMARKERS: LABEL-FREE QUANTIFICATION OF PROTEINS IN THE SECRETÓME OF ARTICULAR CARTILAGE
  287. 451 STRATEGIES FOR OPTIMISING PROTEOMIC STUDIES OF THE CARTILAGE SECRETOME: ESTABLISHING THE TIME COURSE FOR PROTEIN RELEASE AND EVALUATING RESPONSES OF EXPLANT CULTURES TO IL-1β, TNF-α AND CARPROFEN
  288. From Multipotent Cells to Fully Differentiated Connective Tissue Cells for Regenerative Medicine: Emerging Applications of Mesenchymal Stem Cells
  289. The role of the membrane potential in chondrocyte volume regulation
  290. Curcumin Modulates Nuclear Factor κB (NF-κB)-mediated Inflammation in Human Tenocytes in Vitro
  291. High throughput proteomic analysis of the secretome in an explant model of articular cartilage inflammation
  292. Applications of Mesenchymal Stem Cells in Cartilage Tissue Engineering- Part 1
  293. Biomarkers of Osteoarthritis: A Review of Recent Research Progress on Soluble Biochemical Markers, Published Patents and Areas for Future Development
  294. Three‐dimensional high‐density co‐culture with primary tenocytes induces tenogenic differentiation in mesenchymal stem cells
  295. Transient receptor potential channels: Emerging roles in health and disease
  296. Cellular localization of aquaporins along the secretory pathway of the lactating bovine mammary gland: An immunohistochemical study
  297. Neuronal Responses in the Brainstem and Hypothalamic Nuclei Following Insulin Treatment During the Late Follicular Phase in the Ewe
  298. Resveratrol-mediated SIRT-1 Interactions with p300 Modulate Receptor Activator of NF- B Ligand (RANKL) Activation of NF- B Signaling and Inhibit Osteoclastogenesis in Bone-derived Cells
  299. Applications of Proteomics to Osteoarthritis, a Musculoskeletal Disease Characterized by Aging
  300. Applications of Mesenchymal Stem Cells in Cartilage Tissue Engineering- Part 1
  301. Biomarkers of Osteoarthritis: A Review of Recent Research Progress on Soluble Biochemical Markers, Published Patents and Areas for Future Development
  302. Applications of proteomics in cartilage biology and osteoarthritis research
  303. Equine transcriptome quantification using human GeneChip arrays can be improved using genomic DNA hybridisation and probe selection
  304. I-09 DIETARY SUPPLEMENTS IN OA: REAL OPPORTUNITY OR UTOPIA?
  305. 214 ROLE OF K(ATP) CHANNELS IN MODULATING GLUT-1 CONTENT IN NORMAL AND OSTEOARTHRITIC HUMAN CHONDROCYTES
  306. 258 EXPRESSION OF TRANSIENT RECEPTOR POTENTIAL VANILLOID (TRPV) CHANNELS IN DIFFERENT PASSAGES OF EQUINE ARTICULAR CHONDROCYTES
  307. 384 COMBINING CHONDROCYTE GENE EXPRESSION, LITERATURE MINING AND PATHWAY/NETWORK ANALYSIS TO EXTRACT BIOLOGICAL INSIGHTS FROM SMALL-SCALE MICROARRAY DATA
  308. 503 QUANTITATIVE VALIDATION OF PROTEINS IDENTIFIED IN THE CARTILAGE SECRETOME IN AN EXPLANT MODEL OF EARLY OSTEOARTHRITIS
  309. 121 PROTEOMIC ANALYSIS OF THE SECRETOME IN AN EXPLANT MODEL OF CANINE ARTICULAR CARTILAGE
  310. The impact of maternal protein restriction during rat pregnancy upon renal expression of angiotensin receptors and vasopressin-related aquaporins
  311. Identification, validation and qualification of biomarkers for osteoarthritis in humans and companion animals: Mission for the next decade
  312. Biomarkers in veterinary medicine: Towards targeted, individualised therapies for companion animals
  313. Curcumin mediated suppression of nuclear factor-κB promotes chondrogenic differentiation of mesenchymal stem cells in a high-density co-culture microenvironment
  314. Expression of the plasma membrane markers aquaporin 1 (AQP1), glucose transporter 1 (GLUT1) and Na, K-ATPase in canine mammary glands and mammary tumours
  315. Curcumin synergizes with resveratrol to stimulate the MAPK signaling pathway in human articular chondrocytes in vitro
  316. Glucose transporter Glut-1 is detectable in peri-necrotic regions in many human tumor types but not normal tissues: Study using tissue microarrays
  317. Expression and Distribution of Na, K-ATPase Isoforms in the Human Uterus
  318. Expression of aquaporin 1 (AQP1) in human synovitis
  319. Immunohistochemical evidence for expression of fast-twitch type sarco(endo)plasmic reticulum Ca2+ ATPase (SERCA1) in German shepherd dogs with dilated cardiomyopathy myocardium
  320. Characterization of a stretch‐activated potassium channel in chondrocytes
  321. Biological actions of curcumin on articular chondrocytes
  322. The lysosomal trafficking regulator interacting protein-5 localizes mainly in epithelial cells
  323. Differential cellular expression of FXYD1 (phospholemman) and FXYD2 (gamma subunit of Na, K-ATPase) in normal human tissues: A study using high density human tissue microarrays
  324. Distribution, expression and functional effects of small conductance Ca-activated potassium (SK) channels in rat myometrium
  325. Matrix metalloproteinases in inflammatory pathologies of the horse
  326. Mesenchymal stem cells in regenerative medicine: Opportunities and challenges for articular cartilage and intervertebral disc tissue engineering
  327. The emerging chondrocyte channelome
  328. On Some Aspects of the Thermodynamic of Membrane Recycling Mediated by Fluid Phase Endocytosis: Evaluation of Published Data and Perspectives
  329. Targeting Matrix Metalloproteinases in Inflammatory Conditions
  330. Biomarkers in veterinary medicine: establishing a new international forum for veterinary biomarker research
  331. Applications of Tissue Microarrays in Renal Physiology and Pathology
  332. Synergistic chondroprotective effects of curcumin and resveratrol in human articular chondrocytes: inhibition of IL-1β-induced NF-κB-mediated inflammation and apoptosis
  333. Interleukin‐1β–Induced Extracellular Matrix Degradation and Glycosaminoglycan Release Is Inhibited by Curcumin in an Explant Model of Cartilage Inflammation
  334. Impaired glucose transporter-1 degradation and increased glucose transport and oxidative stress in response to high glucose in chondrocytes from osteoarthritic versus normal human cartilage
  335. Proteomic identification and profiling of canine lymphoma patients
  336. Proteomic identification and profiling of canine lymphoma patients*
  337. Effects of hypoxia on glucose transport in primary equine chondrocytes in vitro and evidence of reduced GLUT1 gene expression in pathologic cartilage in vivo
  338. Comment on: comparison between chondroprotective effects of glucosamine, curcumin and diacerein in IL-1β-stimulated C-28/I2 chondrocytes
  339. The contribution of the synovium, synovial derived inflammatory cytokines and neuropeptides to the pathogenesis of osteoarthritis
  340. Resveratrol suppresses interleukin-1β-induced inflammatory signaling and apoptosis in human articular chondrocytes: Potential for use as a novel nutraceutical for the treatment of osteoarthritis
  341. Co-culture of canine mesenchymal stem cells with primary bone-derived osteoblasts promotes osteogenic differentiation
  342. A40 PROTEOMIC IDENTIFICATION OF SECRETED BIOMARKERS IN AN EXPLANT MODEL OF EARLY OSTEOARTHRITIS
  343. 202 DYSREGULATION OF GLUCOSE TRANSPORT AND GLUT-1 PROTEIN IN OSTEOARTHRITIC CHONDROCYTES IN RESPONSE TO HIGH EXTRACELLULAR GLUCOSE
  344. 516 CURCUMIN (DIFERULOYLMETHANE) BLOCKS Il-1β STIMULATED GLYCOSAMINOGLYCAN AND PROSTAGLANDIN E2 RELEASE FROM CARTILAGE EXPLANTS IN AN IN VITRO MODEL OF OSTEOARTHRITIS
  345. Aquaporin expression in the human intervertebral disc
  346. Expression of glucose transporters GLUT-1, GLUT-3, GLUT-9 and HIF-1α in normal and degenerate human intervertebral disc
  347. Diverse Roles of Integrin Receptors in Articular Cartilage
  348. Facilitative Glucose Transporters in Articular Chondrocytes
  349. Articular Cartilage: Structure, Function, and Pathophysiology
  350. Concluding Remarks
  351. Does Arthritis Have a Nutritional Etiology?
  352. Glucose Transporter Expression and Regulation in Embryonic and Mesenchymal Stem Cells
  353. Glucose Transporters in the Intervertebral Disc
  354. Glucose: An Essential Metabolite and Structural Precursor for Articular Cartilage
  355. Integrins in Articular Cartilage
  356. Introduction
  357. Introduction
  358. Mammalian Sugar Transporter Families: GLUT and SGLT
  359. Metabolic Dysfunction in Arthritis
  360. Molecular Diversity of Facilitative Glucose Transporters in Articular Chondrocytes
  361. Regulation of Glucose Transport by Nonsteroidal Anti-inflammatory Drugs
  362. 224 DIFFERENCES IN INTRACELLULAR Na+ AND K+ CONCENTRATIONS BY SUPERFICIAL AND DEEP HUMAN ARTICULAR CHONDROCYTES
  363. 225 EXTRACELLULAR NA+ CONCENTRATION IN HUMAN CARTILAGE: IMPLICATIONS FOR IGF, IL-1 AND TNFα SYNTHESIS BY CHONDROCYTES
  364. Chondrogenesis, osteogenesis and adipogenesis of canine mesenchymal stem cells: a biochemical, morphological and ultrastructural study
  365. Colony-stimulating factors in veterinary medicine: An unexplored potential
  366. Suppression of NF-κB activation by curcumin leads to inhibition of expression of cyclo-oxygenase-2 and matrix metalloproteinase-9 in human articular chondrocytes: Implications for the treatment of osteoarthritis
  367. Expression and nephron segment-specific distribution of major renal aquaporins (AQP1-4) in Equus caballus, the domestic horse
  368. Evidence for functional ATP-sensitive (KATP) potassium channels in human and equine articular chondrocytes
  369. Hypoxic Regulation of Glucose Transport, Anaerobic Metabolism and Angiogenesis in Cancer: Novel Pathways and Targets for Anticancer Therapeutics
  370. Resveratrol Inhibits IL‐1β–Induced Stimulation of Caspase‐3 and Cleavage of PARP in Human Articular Chondrocytes in Vitro
  371. Distribution of the AQP4 Water Channel in Normal Human Tissues: Protein and Tissue Microarrays Reveal Expression in Several New Anatomical Locations, including the Prostate Gland and Seminal Vesicles
  372. Regulation of 2‐Deoxy‐d‐Glucose Transport, Lactate Metabolism, and MMP‐2 Secretion by the Hypoxia Mimetic Cobalt Chloride in Articular Chondrocytes
  373. Igf-I extends the chondrogenic potential of human articular chondrocytes in vitro: Molecular association between Sox9 and Erk1/2
  374. A new low temperature method for high yield isolation of chondrocytes from elderly human subjects and its applicability to mature articular cartilage from older animals
  375. Glucose Sensing in Chondrocytes via GLUT1 and GLUT3: Implications for Articular Cartilage and Intervertebral Disc Metabolism
  376. P172 CURCUMIN AND RESVERATROL REDUCE LIPOPOLYSACCHARIDE MEDIATED GLYCOSAMINOGLYCAN RELEASE IN AN EXPLANT MODEL OF CANINE ARTICULAR CARTILAGE
  377. P179 GLUCOSE TRANSPORT IN IMMORTALIZED HUMAN CHONDROCYTES (C-28/I2) IN NORMOXIA AND HYPOXIA
  378. A hypothesis for the origin and pathogenesis of rheumatoid diseases
  379. Curcumin protects human chondrocytes from IL-1β-induced inhibition of collagen type II and β1-integrin expression and activation of caspase-3: An immunomorphological study
  380. Heterogeneous expression of the aquaporin 1 (AQP1) water channel in tumors of the prostate, breast, ovary, colon and lung: A study using high density multiple human tumor tissue microarrays
  381. Expression of the GLUT1 and GLUT9 facilitative glucose transporters in embryonic chondroblasts and mature chondrocytes in ovine articular cartilage
  382. Nutraceutical Therapies for Degenerative Joint Diseases: A Critical Review
  383. Quantitative analysis of voltage-gated potassium currents from primary equine (Equus caballus) and elephant (Loxodonta africana) articular chondrocytes
  384. Differential regulation of the GLUT1 and GLUT3 glucose transporters by growth factors and pro-inflammatory cytokines in equine articular chondrocytes
  385. Distribution of AQP2 and AQP3 water channels in human tissue microarrays
  386. Vimentin-Positive, c-KIT-Negative Interstitial Cells in Human and Rat Uterus: A Role in Pacemaking?1
  387. Effects of Curcumin (Diferuloylmethane) on Nuclear Factor κB Signaling in Interleukin‐1β‐Stimulated Chondrocytes
  388. Aquaporin water channels AQP1 and AQP3, are expressed in equine articular chondrocytes
  389. Cultivation of human tenocytes in high-density culture
  390. Immunohistochemical localization of aquaporin�10 in the apical membranes of the human ileum: a potential pathway for luminal water and small solute absorption
  391. Loss of chondrogenic potential in dedifferentiated chondrocytes correlates with deficient Shc–Erk interaction and apoptosis
  392. Chronic equine laminitis is characterised by loss of GLUT1, GLUT4 and ENaC positive laminar keratinocytes
  393. Expression of the AQP-1 water channel in normal human tissues: a semiquantitative study using tissue microarray technology
  394. Regeneration influences expression of the Na+,K+-atpase subunit isoforms in the rat peripheral nervous system
  395. Expression and cellular localization of Na,K‐ATPase isoforms in the rat ventral prostate
  396. Apoptosis and the loss of chondrocyte survival signals contribute to articular cartilage degradation in osteoarthritis
  397. Expression of the VEGF receptor-3 in osteoarthritic chondrocytes: stimulation by interleukin-1? and association with ?1-integrins
  398. Chondrocyte apoptosis, inflammatory mediators and equine osteoarthritis
  399. Expression and Cellular Localization of Na,K‐ATPase Isoforms in Dog Prostate in Health and Disease
  400. Na,K‐ATPase Isoforms in Pregnant and Nonpregnant Rat Uterus
  401. Molecular characterization and partial cDNA cloning of facilitative glucose transporters expressed in human articular chondrocytes; stimulation of 2-deoxyglucose uptake by IGF-I and elevated MMP-2 secretion by glucose deprivation
  402. ATPase pumps in osteoclasts and osteoblasts
  403. HUMAN ARTICULAR CHONDROCYTES EXPRESS THREE FACILITATIVE GLUCOSE TRANSPORTER ISOFORMS: GLUT1, GLUT3 AND GLUT9
  404. Role of chondrocyte death and hypocellularity in ageing human articular cartilage and the pathogenesis of osteoarthritis
  405. INTEGRINS AND STRETCH ACTIVATED ION CHANNELS; PUTATIVE COMPONENTS OF FUNCTIONAL CELL SURFACE MECHANORECEPTORS IN ARTICULAR CHONDROCYTES
  406. Role of extensin peroxidase in tomato ( Lycopersicon esculentum Mill.) seedling growth
  407. Progress in neuropharmacology and neurotoxicology of pesticides and drugs. Edited by DJ Beadle, The Royal Society of Chemistry, Cambridge, 1999 ISBN 0 85404 729 8
  408. Epithelial sodium channels in skeletal cells; a role in mechanotransduction?
  409. Molecular Aspects of Cell Wall Modifications during Fruit Ripening
  410. EXPRESSION OF CATION EXCHANGER NHE AND ANION EXCHANGER AE ISOFORMS IN PRIMARY HUMAN BONE‐DERIVED OSTEOBLASTS
  411. Inhibition of Na+, K+-ATPase activates swelling-induced taurine efflux in a human neuroblastoma cell line
  412. CHARACTERIZATION OF THE Na+K+‐ATPase IN ISOLATED BOVINE ARTICULAR CHONDROCYTES; MOLECULAR EVIDENCE FOR MULTIPLE α AND β ISOFORMS
  413. Immunologic and autoradiographic localisation of the Na+, K+-ATPase in articular cartilage: Upregulation in response to changes in extracellular Na+ concentration
  414. Potassium Ion Channels in Articular Chondrocytes
  415. Regeneration of Articular Cartilage
  416. Faculty of 1000 evaluation for Sleep disturbance in osteoarthritis: linkages with pain, disability, and depressive symptoms.
  417. Faculty of 1000 evaluation for Synergy between Piezo1 and Piezo2 channels confers high-strain mechanosensitivity to articular cartilage.
  418. Faculty of 1000 evaluation for An investigation of the false discovery rate and the misinterpretation of p-values.
  419. Faculty of 1000 evaluation for The chondrocyte clock gene Bmal1 controls cartilage homeostasis and integrity.